Search Results

Veravas, Inc., an emerging diagnostic company focusing on sample preparation products and new diagnostic tests and MIP Diagnostics Ltd., the Molecularly Imprinted Polymers (MIPs) specialist based in Sharnbrook, United Kingdom, announced today that they have entered into a mutually beneficial agreement for the development, license, and supply of a novel MIP specific for Veravas’ proprietary sample preparation technology.

Veravas, Inc., an emerging diagnostic company, appointed eight members to its Advisory Board.

Feb. 19, 2020 13:04 UTC CHARLESTON, S.C. & OAKDALE, Minn.--( BUSINESS WIRE )-- Veravas, Inc. , a diagnostic company founded in Charleston, S.C., announced today a significant milestone, reaching a total of $4 million in funding from private investors through the issuance of convertible notes. Veravas develops proprietary sample pretreatment products and new diagnostic tests to provide laboratories with high-value solutions for the accurate diagnoses of some of the world’

Veravas, Inc. and Tymora Analytical Operations, LLC announced that they have entered into a strategic alliance to explore the integration of their respective technologies.

Veravas, Inc., an emerging diagnostic company, today announced the appointment of Carroll E. Streetman Jr., as chief executive officer.

True Diagnostics, Inc. and Veravas announced their Strategic Alliance in the commercialization of VeraTest Biotin, a portable and easy-to-use digital qualitative test that can rapidly screen patient samples to determine if significant biotin is present, helping safeguard against potential biotin interference.